The Asia-Pacific Clinical Data Analytics Market was worth $0.77 billion in 2018 and estimated to be growing at a CAGR of 48.92%, to reach $5.64 billion by 2023. The market is showing significant potential in the mentioned forecasting period. The market continues to grow rapidly with the growth of Big data industry within the healthcare. Big data has been responsible for showing better results in improving healthcare, saving lives and that too at low costs.
Clinical Data Analytics assist physicians and doctors in making decisions related to a patient’s care and help in getting a better knowledge of the healthiness of the demographics. The technology shows variation based on the data required or the potential users of the information which may include any of the nurses, doctors, public health officials etc.
The population is getting more focused towards health management lately. It constitutes for one of the major factors driving the Clinical Data Analytics market. Other factors responsible for the growth of market include supportive government policies, cost benefits and better opportunities to provide high quality services to patients. Some of the challenges and restraints faced by Clinical Data Analytics market include end user market fragmentation, software privacy issues, security issues.
The Asia-Pacific market for Clinical Data Analytics is segmented based on Deployment Model, Services and End Use Sector. Based on the deployment model the market for Clinical Data Analytics is segmented into Cloud and On-Premise. Further, under services the segmentation is done into Consulting and Maintenance, and under End use sector the segmentation is done into Pharmaceuticals, Healthcare Providers, Biotechnology and Academia. On-Premise segmentation accounted for higher share compared to the Cloud segmentation. Similarly Consulting and Pharmaceuticals segmentations exhibit the highest share in their respective segments. On the basis of geographical analysis, the Asia-Pacific market is analysed under various countries namely China, India, Japan, Australia and South Korea.
Some of the companies leading the Clinical Data Analytics market are IBM, Athenahealth, CareEvolution, Caradigm, Cerner, Intersystems, Explorys, Wellcentive, McKesson, Truven Health Analytics.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Deployment Model
5.1.1 Introduction
5.1.2 Cloud
5.1.3 On-Premise
5.1.4 Y-o-Y Growth Analysis, By Deployment Model
5.1.5 Market Attractiveness Analysis, By Deployment Model
5.1.6 Market Share Analysis, By Deployment Model
5.2 Services
5.2.1 Introduction
5.2.2 Consulting
5.2.3 Maintenance
5.2.4 Y-o-Y Growth Analysis, By Services
5.2.5 Market Attractiveness Analysis, By Services
5.2.6 Market Share Analysis, By Services
5.3 End Use Sector
5.3.1 Introduction
5.3.2 Pharmaceuticals
5.3.3 Healthcare Providers
5.3.4 Biotechnology
5.3.5 Academia
5.3.6 Y-o-Y Growth Analysis, By End Use Sector
5.3.7 Market Attractiveness Analysis, By End Use Sector
5.3.8 Market Share Analysis, By End Use Sector
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Deployment Model
6.1.3.3 By Services
6.1.3.4 By End Use Sector
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Deployment Model
6.1.4.3 By Services
6.1.4.4 By End Use Sector
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Deployment Model
6.1.5.3 By Services
6.1.5.4 By End Use Sector
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 IBM
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 CareEvolution
8.3 Cardigm
8.4 Explorys
8.5 Cerner
8.6 Intersystems
8.7 Athenahealth
8.8 Truven Health Analytics
8.9 Wellcentive
8.10 McKesson
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
